Innovating Works
SERAS_v4.0: Seizure Risk Asessment for Epilepsy MJN NEUROSERVEIS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 MJN Neuroserveis’ has developed SERAS, a non-invasive, discrete and wearable device that predicts an epileptic seizure before it occurs. The...
2019-03-13 - 2022-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.